$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
吃厄达替尼能活多久,疗效好吗?
2025-10-19 11:44:20
Check Details
恩诺单抗2022最新价格,多少钱一支?
2025-10-19 11:44:20
Check Details
恩诺单抗治疗尿路上皮癌:Ⅱ期多中心研究中客观缓解率为44%!
2025-10-19 11:44:20
Check Details
厄达替尼常见的不良反应你知道哪些?
2025-10-19 11:44:20
Check Details
厄达替尼容易出现的副作用有哪些?
2025-10-19 11:44:20
Check Details
Enfortumab vedotin-ejfv副作用多不多?要注意什么
2025-10-19 11:44:20
Check Details
厄达替尼副作用大吗?
2025-10-19 11:44:20
Check Details
杨森制药的厄达替尼不良反应有哪些?
2025-10-19 11:44:20
Check Details
杨森制药的厄达替尼副作用要怎么处理?
2025-10-19 11:44:20
Check Details
恩诺单抗2023价格多少钱一支?
2025-10-19 11:44:20
Check Details
厄达替尼(BALVERSA)治疗局部晚期或转移性尿路上皮癌的效果?
2025-10-19 11:44:20
Check Details
恩诺单抗(Padcev)可使尿路上皮癌死亡风险降低30%
2025-10-19 11:44:20
Check Details
1
2
...
46
47
48
49
50
51
52
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
2
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
3
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
4
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
5
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
6
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
7
Adagrasib Medication Management Guide for Special Populations
8
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
9
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
10
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
11
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
12
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers